AbbVie Inc. — Form 10-Q
Filed November 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Robert A. Michael (CEO) and Scott T. Reents (CFO) certified on November 3, 2026 that the Q3 2026 10-Q fairly presents AbbVie's financial condition and results of operations, that disclosure controls and internal controls over financial reporting are effective, and that no material weaknesses or fraud involving management were identified. These are routine Sarbanes-Oxley 302/906 certifications required by law.
Why this rating
Boilerplate regulatory certifications; no substantive business event, transaction, or control deficiency disclosed.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.